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Abstract
Intrahepatic transplantation of donor islets of Langerhans is a promising therapy for patients with type 1 diabetes. It is
of critical importance to accurately monitor islet quality before transplantation, which is currently done by standard
histological methods that are performed off-line and require extensive sample preparation. As an alternative, we
propose Raman spectroscopy which is a non-destructive and label-free technique that allows continuous real-time
monitoring of the tissue to study biological changes as they occur. By performing Raman spectroscopic
measurements on purified insulin and glucagon, we showed that the 520 cm-1 band assigned to disulfide bridges in
insulin, and the 1552 cm-1 band assigned to tryptophan in glucagon are mutually exclusive and could therefore be
used as indirect markers for the label-free distinction between both hormones. High-resolution hyperspectral Raman
imaging for these bands showed the distribution of disulfide bridges and tryptophan at sub-micrometer scale, which
correlated with the location of insulin and glucagon as revealed by conventional immunohistochemistry. As a
measure for this correlation, quantitative analysis was performed comparing the Raman images with the fluorescence
images, resulting in Dice coefficients (ranging between 0 and 1) of 0.36 for insulin and 0.19 for glucagon. Although
the use of separate microscope systems with different spatial resolution and the use of indirect Raman markers
cause some image mismatch, our findings indicate that Raman bands for disulfide bridges and tryptophan can be
used as distinctive markers for the label-free detection of insulin and glucagon in human islets of Langerhans.
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Introduction
Type 1 diabetes is a chronic disease that is characterized by
uncontrollable hyperglycemia, caused by the autoimmune
destruction of beta-cells. This results in loss of insulin
production, requiring patients to self-administer exogenous
insulin daily to control blood sugar levels. Type 1 diabetes
affects up to 20 million people worldwide [1]. The annual
incidence rate of juvenile (age < 15) type 1 diabetes varies
globally, from less than 1/100,000 in most Asian countries to
37/100,000 in certain areas of Europe, and this number is
predicted to rise rapidly in the coming years [2-4]. Over time,
diabetes can damage the heart, blood vessels, eyes, kidney
and nerves, increasing the risk of developing life-threatening
diseases such as heart disease, stroke, and kidney failure [5].
Consequently, diabetes and its complications have a
significantly adverse economic impact [6]. Type 1 diabetes
patients who suffer from severe hypoglycemia unawareness
upon daily injections of insulin, or patients who have had a
kidney transplant and take immunosuppressant drugs, benefit
from intrahepatic transplantation of donor islets of Langerhans
as an alternative to whole pancreas transplantation. In this
procedure, purified islets extracted from donor pancreata are
infused into the portal vein of the patient’s liver [7]. Although
the initial clinical results are promising, only a minority
(approximately 10%) of the patients were insulin-independent 5
years after treatment [8,9]. The need for ongoing
immunosuppressive therapy and the scarcity of donor islets
have limited its widespread clinical use.
To ensure successful transplantation, it is crucial to
accurately assess critical parameters such as beta-cell mass
and viability [10,11]. Conventional methods to characterize the
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transplant include staining with dithizone
(diphenylthiocarbazone, DTZ) to determine islet purity, live/
dead assays to assess cell viability, immunohistochemistry to
locate insulin and glucagon, and glucose-induced-insulin-
release-test (GIIST) to assess islet function. These methods
are invasive, requiring sample preparation and labeling, which
prohibits real-time monitoring of the tissue. Other studies have
shown non-invasive in vivo monitoring of beta-cells and islets
using MRI [12], bioluminescence [13] and nuclear imaging [14].
However, the spatial resolution of these methods is usually
limited, which does not allow imaging at the individual cell level.
As an alternative, we propose the use of Raman
spectroscopy for the non-destructive and label-free
characterization of islets of Langerhans. Raman spectroscopy
is an analytical technique that is based on the inelastic
scattering of monochromatic light [15]. Upon interaction with
the sample, a small fraction of the light (1 in 106-108 photons) is
emitted with a different wavelength from the incident light. This
wavelength shift is specific for the chemical bonds within the
sample, providing a fingerprint of its entire molecular
composition [16].
Raman spectroscopy enables characterization of living cells
and tissues under physiological conditions, and is widely used
in biological applications [17-20]. Rong et al. demonstrated the
real-time monitoring of single rat pancreatic beta-cells using
Raman microspectroscopy [21]. Moreover, Raman and infrared
spectroscopy have been used for diagnosis of various
diseases, including type 1 diabetes [22,23]. Using pattern-
recognition methods, metabolic fingerprints of human serum
samples were correlated to disease state [24]. At present, no
spectroscopic measurements of human pancreatic islets have
yet been reported. This study demonstrates the feasibility of
using Raman microspectroscopy to characterize islets of




MIN6-B1 mouse insulinoma cells (kindly provided by Dr. P.
Halban, University Medical Center, Geneva, Switzerland) [25]
were cultured in high-glucose DMEM with 2.5mM L-glutamine
(Invitrogen) supplemented with 10% FBS, 100 U/ml
streptomycin, 100 μg/ml penicillin and 70μM freshly added
beta-mercaptoethanol. INS-1E rat insulinoma cells (kindly
provided by Dr. B. Guigas, LUMC, Leiden, The Netherlands
and Dr. P. Maechler, University Medical Center, Geneva,
Switzerland) [26] were cultured in RPMI with 2.05 mM L-
glutamine (Invitrogen) supplemented with 5% FBS, 100 U/ml
streptomycin, 100 μg/ml penicillin, 10 mM HEPES, 1 mM
sodium pyruvate, 50 μM freshly added beta-mercaptoethanol.
AlphaTC1-6 rat alpha-cells (ATCC, Manassas, USA) were
cultured in high-glucose DMEM with 2.5mM L-glutamine
(Invitrogen) supplemented with 10% FBS, 100 U/ml
streptomycin, 100 μg/ml penicillin, 15 mM HEPES, 1 mM
sodium pyruvate, 0.1 mM non-essential amino acids, 0.02%
bovine serum albumin. Cell cultures were maintained at 37°C
in humidified air containing 5% carbon dioxide. Medium was
refreshed every 3 to 4 days and cells were replated when 80%
confluency was reached.
Human islet culture
Human cadaveric donor pancreata (provided by the Leiden
University Medical Center, Leiden, The Netherlands) were
procured through a multi-organ donor program. Tissue samples
from the pancreata were used in the study if research consent
was present and pancreata could not be used in clinical beta-
cell therapy programs according to national laws. Islets were
dispersed into single cells by adding 0.025% trypsin solution
containing 10 µg/mL DNase (Pulmozyme, Genentech) and
seeded onto agarose microwells for controlled cell aggregation.
Intact islets and human islet cell aggregates were cultured in
CMRL 1066 medium (5.5 mM glucose) (Mediatech)
supplemented with 10% FCS, 20 μg/ml ciprofloxacin, 50 μg/ml
gentamycin, 2 mM L-glutamin, 0.25 μg/ml fungizone, 10 mM
HEPES and 1.2 mg/ml nicotinamide. Cell cultures were
maintained at 37°C in a 5% CO2 humidified atmosphere.
Medium was refreshed every 3 to 4 days.
Immunohistochemistry
To visualize insulin and glucagon, human islets were fixed in
PBS containing 4% (w/v) paraformaldehyde, incubated
overnight in 20% sucrose at 4°C, embedded in cryomatrix
(Thermo Scientific), and sectioned (8 μm) using a cryotome
(Shandon). Blocking was done with 0.1% (w/v) normal donkey
serum/PBS for 1 hour and antibodies were diluted in 1% lamb
serum/PBS. Primary antibodies used were: 1:100 rabbit-anti-
glucagon (Vector Labs) incubated overnight at 4°C and 1:200
guinea pig-anti-insulin (ABCAM) incubated for 1.5 hours at
21°C. Secondary antibodies used were: 1:200 biotin donkey
anti-rabbit (Jackson ImmunoResearch), 1:200 streptavidin-
Alexa488 (Invitrogen), 1:400 rhodamine donkey anti-guinea pig
(Jackson ImmunoResearch), all incubated for 1 hour at 21°C.
Counterstaining was performed with 1 µg/mL 4'-6-diamidino-2-
phenylindole (DAPI). Fluorescence was visualized using a
Nikon Eclipse E600 microscope.
Confocal Raman microspectroscopy
UV-grade calcium fluoride (CaF2) slides (Crystan LTD) were
used as sample substrates, because of their low background
signal. Purified human recombinant insulin and synthetic
glucagon (Sigma), both in powder form, were placed on CaF2
slides. For cells and islet preparations, CaF2 slides were first
sterilized using 70% ethanol and coated with 0.01% poly-L-
lysine (Sigma). INS-1E, alphaTC6 and MIN6 cells were seeded
on coated CaF2 slides at 30,000 cells/cm2, allowed to attach
overnight, fixed using 10% buffered formalin, and kept in PBS.
Cryosections of human islets were placed on coated CaF2
slides. Subsequently, slides were washed in demiwater and air-
dried. Raman spectra were acquired using a confocal Raman
microspectrometer, similar to the setup described previously
[27]. Briefly, a krypton ion laser (Innova 90-K, Coherent Inc.)
emitting at 647.1 nm at a power of 35mW under the objective
was used as the excitation source. A 63x/1.0NA water
immersion objective (Zeiss W-plan Apochromat) or a 40×/0.75
NA objective (Olympus UPFLN) was used to focus the laser
Label-Free Detection of Hormones in Human Islets
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light over the sample. The Raman scattered photons were
collected and dispersed on an air-cooled electron-multiplying
charge-coupled device (EMCCD; Newton DU-970N, Andor
Technology). Raman spectra were acquired in “Raman imaging
mode”, in which images were obtained by stepping the laser
beam over the sample in a raster pattern, while collecting
complete spectral information during each step. Average
Raman fingerprints of the single cells were obtained by
scanning a 32x32 raster pattern over a sample area of 20x20
µm with a step size of 0.6 µm and an accumulation time of 0.5
s/step, resulting in datasets consisting of 1024 spectra per 400
µm2 encompassing a single cell. Three-level cluster analysis
was performed to separate the spectra corresponding to the
cytoplasm and the spectra corresponding to the cell nucleus
from the background spectra. Spectral data from 5 randomly
chosen cells was averaged. Raman imaging on beta-cells was
performed by scanning a 64x64 raster pattern over a sample
area of 20x20 µm with a step size of 0.3 µm, and an
accumulation time of 1s/step. Raman imaging on human islet
sections was performed by making 16 (4x4) subsequent scans,
each consisting of a 16x16 raster pattern over an area of 30x30
µm with a step size of 1.88 µm and an accumulation time of
0.5s/step. The scans were made exactly 30 µm from each
other by using a Kleindiek LT6820 microscope substage
controlled by a Kleindiek NanoControl (Kleindiek Nanotechnik,
Reutlingen, Germany). The spectral data of the scans were
then combined (using MATLAB 7.6, The MathWorks) in one
large data matrix consisting of 4096 spectra, covering a total
sample area of 120x120 µm. High-resolution Raman imaging
on subparts of the islet preparations were performed by
scanning a 32x32 raster pattern over a sample area of 30x30
µm with a step size of 0.94 µm and an accumulation time of 1s/
step.
Raman data analysis
Raman spectra were preprocessed, as described previously
[28,29], by: (1) removing cosmic ray events; (2) subtracting
camera offset; (3) calibration of the wave number axis; and (4)
correction of frequency-dependent transmission. The well-
known band-positions of toluene were used to relate
wavenumbers to pixels [30]. The frequency-dependent optical
detection efficiency of the setup was corrected using a
tungsten halogen light source (Avalight-HAL; Avantes BV) with
a known emission spectrum. The detector-induced etaloning
effect was also compensated by this procedure. Noise in the
3D (spatial x spatial x spectral dimension) data matrix was
reduced by singular value decomposition. Univariate and
multivariate analyses were performed over the hyperspectral
Raman data as described previously [28,31]. Univariate
analysis was performed by a selection of specific vibrational
bands of interest and an integration of the band intensity after
local baseline subtraction. Multivariate analysis, involving both
principal component analysis (PCA) and hierarchical cluster
analysis (HCA) using Ward’s clustering method, was performed
on Raman imaging data matrices to visualize regions in cells
with high Raman spectral similarities [32,33]. Data for PCA was
preprocessed by auto-scaling to the mean of the spectra along
the frequency axis. HCA makes use of the scores obtained
from the PCA data and was preprocessed with a first derivative
Savitsky-Golay algorithm (with seven-point smoothing and
quadratic polynomial fit) to minimize small variations in the
baseline, and subsequently auto-scaled to the mean of the
spectra along the frequency axis. For quantitative comparison
between Raman and fluorescence imaging, the Dice coefficient
[34] was calculated as follows: 2h/(a+b), in which h is the
overlap between the two (binary) images, and a and b
represent the surface areas in the separate images. The Dice
coefficient ranges from 0 to 1, in which 0 indicates no overlap
and 1 indicates perfect agreement. All data manipulations were
performed in routines written in MATLAB 7.6 (The MathWorks).
HCA and PCA were performed using PLS toolbox
(Eigenvectors Research Inc.).
Results
Raman spectra of purified hormones
Raman spectroscopy on purified hormones was performed to
identify Raman markers for insulin and glucagon, the two main
hormones within the islets of Langerhans produced by the
beta-cells (50-70%) and alpha-cells (20-35% of islet cells),
respectively [35,36]. Spectra a and b in Figure 1A represent the
Raman spectra of insulin and glucagon. Similarities in the
spectra are mainly caused by vibrations in phenylalanine and
tyrosine, amino acids that are part of the molecular structure of
both insulin and glucagon. More interestingly, spectral
differences between the two hormones were observed that
could be explained by their molecular structure (Figure 1B).
Insulin contains six cysteine groups that are linked with three
disulfide (S-S) bridges. Molecular vibrations of these bridges
result in specific Raman bands at 520 cm-1 (S-S vibration) and
662 cm-1 (C-S stretching) [37-39]. Tryptophan, one of the
building blocks of glucagon, has molecular vibrations that result
in Raman bands at 759 (aromatic ring breathing) and 1552 cm-1
(C=C vibration) [37]. Because tryptophan is not present in
insulin and disulfide bridges are not present in glucagon, these
Raman bands may be used to distinguish between insulin and
glucagon. However, since both tryptophan and disulfide
bridges between cysteines are also present in other
polypeptides, these amino acids may only serve as indirect
markers of glucagon and insulin.
Additionally, we measured a number of other hormones that
are produced by islets of Langerhans, albeit in much lower
amounts than insulin and glucagon. Amylin is co-secreted with
insulin by beta-cells (molar ratio amylin to insulin ~2:100) [40],
somatostatin is produced by delta-cells (<10% of total islet
cells), and pancreatic polypeptide is produced by PP-cells
(<5% of cells) [36]. Pancreatic polypeptide does not contain
any tryptophan or cysteine groups, reflected by the absence of
the corresponding Raman bands. The polypeptides amylin and
somatostatin both contain one disulfide bridge, which in
contrast to the three bridges in insulin, results in strongly
reduced bands at 520 and 662 cm-1. Like glucagon,
somatostatin contains one amino acid tryptophan and thus also
shows Raman bands at 759 and 1552 cm-1 (Figure 1A).
Label-Free Detection of Hormones in Human Islets
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Figure 1.  Confocal Raman spectroscopy of purified hormones.  (A) Raman fingerprint of insulin (a), glucagon (b), amylin (c),
somatostatin (d), pancreatic polypeptide (e). Spectra are vertically offset for clear representation. Bands specific for sulfide bridges
between cysteines in insulin were found at 520 and 662 cm-1. Tryptophan-specific bands at 759 and 1552 cm-1 were found in
spectrum of glucagon. (B) Amino acid composition of insulin (a), containing three Raman-active sulfide bridges between cysteine
groups, and glucagon (b), containing the Raman-active amino acid tryptophan.
doi: 10.1371/journal.pone.0078148.g001
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Raman fingerprint of alpha- and beta-cell lines
Raman spectral mapping was performed on INS-1E rat
insulinoma beta-cells, MIN6 mouse insulinoma beta-cells and
alphaTC6 rat alpha-cells. The averaged spectra (n=5) for each
cell type are shown in Figure 2A. The spectra show several
bands characteristic for cells and biological samples, which can
be assigned to DNA (788 cm-1), phenylalanine (1002 cm-1),
proteins (1152 cm-1), lipids and amides (1245-1280 cm-1), CH2
bending of proteins and lipids (1447 cm-1), and C=C groups in
unsaturated fatty acids (1659 cm-1). HCA on the averaged total
cell spectra successfully classifies the spectra in three separate
clusters. Although there is some variation within one cell type,
the variance between the spectra of one cell type is much
smaller than the variance between the spectra of the different
cell types (Figure 2B).
In addition to the total cell spectra, we have investigated the
molecular fingerprint of just the cytoplasm of the cell, where
proteins are stored in the secretory vesicles. A three-level
cluster analysis was performed to separate the spectra
corresponding to the cytoplasm from the spectra corresponding
to the nucleus or background. Principal component analysis
(PCA) was performed for unsupervised analysis of the
cytoplasm spectra. This method assigns scores to reveal
subsequent levels of variation in the dataset, with the first
principal component (PC) reflecting the highest amount of
variation. Each spectrum in the dataset acquires a score with
respect to each level of variation. Following the analysis it was
observed that the third principal component (responsible for
1.4% of the variance) accounts for the separation of the alpha-
cell line from the beta-cell lines. PC1 (91.5%) and PC2 (6.1%)
did not contribute to distinguish the various cell types, and
represent intercellular variation. Figure 2C shows the individual
scores of PC3 for each Raman spectrum analyzed, in which
two distinct groups were observed. The INS-1E and MIN6 beta-
cells are characterized by negative PC3 scores, while the
alphaTC6 alpha-cells show positive PC3 scores. To determine
the biochemical features that are responsible for clustering of
the two groups, the loadings on PC3 were analyzed (Figure
2D). The PC3 loadings spectrum shows bands at 1264, 1298,
1440 and 1660 cm-1, which resemble lipid contributions of
predominantly unsaturated fatty acids. In addition, the band at
716 cm-1 is characteristic for the phospholipid
phosphatidylcholine. This indicates that differences in
intracellular lipid concentration account for the classification of
(alphaTC6) alpha-cells and (MIN6 and INS-1E) beta-cells.
Raman imaging of INS-1E beta-cells
High-resolution Raman imaging is performed on individual
INS-1E cells to identify intracellular insulin. INS-1E cell
morphology was examined using bright field microscopy and
the same cell was imaged using Raman microspectroscopic
scanning (Figure 3A). Three-level hierarchical cluster analysis
of the dataset was performed, resulting in the Raman cluster
image (Figure 3B). This illustrates the spatial variation of the
Figure 2.  Raman spectroscopic evaluation of insulinoma cell lines.  (A) Average Raman fingerprints of MIN6 (a), INS-1E (b)
and alpha-TC6 (c) cells were acquired by averaging the spectra of 5 randomly chosen individual cells. Spectra are vertically offset
for clear representation. (B) Multivariate data analysis was applied to the dataset to objectively assess subtle differences in the
fingerprint region of the spectra. Hierarchical cluster analysis (HCA) classifies the various cell types in separate clusters. (C) PC3
scores from PCA on spectra of the cell cytoplasm clearly distinguish the alpha from the beta cells. Black circles: MIN6 cells, red
triangles: INS-1E cells, blue squares: alpha-TC6 cells. (D) PC3 loadings indicate the Raman bands that are mainly involved in the
separation of alpha and beta cells. Band positions characteristic for unsaturated fatty acids are marked with an asterisk.
doi: 10.1371/journal.pone.0078148.g002
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Raman signal by distinguishing the nucleus (red cluster) and
cytoplasm of the cell (purple cluster) from the background
(black cluster). Figure 3C shows the corresponding cluster
spectra for nucleus and cytoplasm, corrected for the
background spectrum. Univariate analysis on selected Raman
bands was performed to visualize the presence and distribution
of specific compounds. The intensity of the 788 cm-1 band for
DNA was used to locate the cell nucleus (Figure 3D), which
corresponds to the red cluster in Figure 3B. Raman mapping of
the 520 cm-1 band shows high local concentrations of disulfide-
bridged cysteine groups which could indicate the accumulation
of insulin in the cytoplasm of the INS-1E cell at these locations
(Figure 3E).
Figure 3.  Label-free Raman imaging of rat insulinoma INS-1E beta-cells.  (A) Brightfield image of a beta-cell. (B) Raman
cluster image acquired by scanning the confocal laser beam in a 64x64 raster pattern. Analysis with 3 levels of clustering illustrates
the spatial variation of Raman signal within a cell by distinguishing subcellular structures. (C) Corresponding Raman cluster spectra
(corrected for background) show the average signal for cytoplasm (magenta) and nucleus (red). Enlargement shows the Raman
band at 520 cm-1, specific for difsulfide-bridged cysteine. Spectra are vertically offset for clear representation. Integrating over
specific Raman bands shows (D) the distribution of DNA (783 cm-1, Δ = 26 cm-1) corresponding to red cluster in B, and (E) the
distribution of disulfide bridges between cysteine groups (524 cm-1, Δ = 30 cm-1). Scale bar represents 10 µm.
doi: 10.1371/journal.pone.0078148.g003
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Raman imaging of human pancreatic islets
We have performed hyperspectral Raman imaging (with a
step size of 1.88 µm) on human donor islets and compared
their spectral characteristics to those of pure insulin and
glucagon. A brightfield microscopy image of a representative
human islet section is shown in Figure 4A. The islets were
stained for insulin and glucagon to visualize the distribution of
alpha- and beta-cells (Figure 4B). Three-level cluster analysis
was performed on the entire fingerprint region to objectively
assess the spatial variation of the Raman signal. The green
and blue clusters, representing the islet, indicate some
variation in the concentration of DNA, lipids and proteins
throughout the tissue (Figure 4C and D). Univariate Raman
spectral imaging was performed to investigate the distribution
of specific compounds within the whole islet section. The
intensity and distribution of the 788 cm-1 band visualizes the
presence of DNA, and was used to identify the cell nuclei in
islet cells. Moreover, the distribution of the Raman band at 520
cm-1 specific for disulfide bridges between cysteine groups, and
the tryptophan band at 1552 cm-1 are depicted in Figure 4E-G.
However, at low resolution these bands did not clearly correlate
with the immunolabeling against insulin and glucagon.
High resolution Raman imaging of human pancreatic
islets
Since proteins are stored in small secretory vesicles in the
cell cytoplasm, we performed high-resolution hyperspectral
Raman imaging with a step size of 0.94 µm on part of the islet
preparation (as indicated by a white square in Figure 4B).
Figure 5A-C visualizes the distribution of Raman bands specific
for DNA, disulfide bridges in cysteine and tryptophan. At this
higher (subcellular) resolution, a clear distribution of these
molecules was observed which coincided with fluorescence
labeling for cell nuclei, insulin and glucagon, respectively
(Figure 5E-G). To compare the obtained Raman images with
images obtained using conventional fluorescence microscopy,
we generated overlay images with the Raman signal in purple
and the fluorescence signal in green (Figure 5I-K). A
quantitative comparison was made by calculating the Dice
coefficient, which gives a value for overlap between the two
images. For DNA, we obtained a Dice coefficient of 0.69
indicating a strong correlation between the Raman signal and
the fluorescence signal, which is depicted in the corresponding
overlay image. We also found a clear correlation for insulin and
glucagon (Figure 5J and K). However, this correlation is
somewhat lower than for DNA resulting in Dice coefficients of
0.36 for insulin and 0.19 for glucagon. The merged Raman
image shows the distribution of DNA, disulfide bridges in
cysteine and tryptophan (Figure 5D), whereas Figure 5H
represents the merged image obtained by conventional
fluorescence immunolabeling.
Discussion
Our study has explored the feasibility of Raman
spectroscopy to identify insulin and glucagon within human
islets of Langerhans. We used Raman spectroscopy to
characterize cell lines and human donor pancreatic islets at the
sub-cellular level.
By performing Raman measurements on purified hormones
we showed that Raman bands specific for disulfide bridges
between cysteine groups in insulin and tryptophan in glucagon
are mutually exclusive, and could therefore be used for the
label-free distinction between both hormones. High-resolution
univariate Raman imaging for the 520 cm-1 band on individual
beta-cells showed the distribution of disulfide bridges in the
cytoplasm of the cells. These findings correlate with the
knowledge that insulin is accumulated in large dense-core
vesicles within the cytoplasm of pancreatic beta-cells and
therefore locally contain high concentrations of cysteine
[41,42], suggesting that Raman spectroscopy allows for the
label-free detection of intracellular insulin.
Subsequently, we investigated whether we could use the
Raman markers specific for disulfide bridges and tryptophan to
distinguish between insulin-producing beta-cells and glucagon-
producing alpha-cells within human islets of Langerhans.
Hyperspectral imaging on human islet preparations with a step
size of 1.88 µm enabled identification of individual cells but did
not provide detailed subcellular information. Since hormones
such as insulin and glucagon are stored in vesicles with an
estimated diameter of 0.3 µm [43], high-resolution
hyperspectral Raman imaging was performed on smaller areas
of the islet preparation in which we decreased the step size
from 1.88 to 0.94 µm, resulting in more detailed information. In
this case every pixel represents 0.88 µm2 of the sample,
providing molecular information on a sub-micrometer level.
Univariate analysis of selected Raman bands was performed to
display the distribution of DNA, disulfide-bridged cysteines and
tryptophan which corresponded with the corresponding
fluorescence microscopy images for DNA, insulin and glucagon
as demonstrated by overlaying the images obtained by both
techniques. We quantitatively compared the correlation
between label-free Raman imaging and conventional
fluorescence microscopy by calculating the Dice coefficients
(DC). The highest Dice coefficient was found for DNA
(DC=0.69), while significantly lower coefficients for insulin
(DC=0.36) and glucagon (DC=0.19) were determined. Several
factors can be attributed to the fact that the images of both
techniques do not perfectly match.
First, because tryptophan and disulfide bridges between
cysteines are also present in other polypeptides, these amino
acids only serve as indirect markers of glucagon and insulin.
However, since both hormones are stored at high
concentrations in secretory granules of alpha- and beta-cells,
this should locally result in strong Raman bands at the
described wavenumbers. Since insulin contains six disulfide-
bridged cysteine groups, whereas glucagon only contains one
tryptophan molecule, we can assume that tryptophan as a
marker for glucagon is less specific than disulfide bridges are
for insulin. In addition, somatostatin produced by delta cells
also contains one tryptophan molecule. Delta cells which
commonly comprise 11% of the islet cell population, whereas
35% is composed of alpha-cells [35], will therefore contribute to
the tryptophan-specific Raman signal.
Label-Free Detection of Hormones in Human Islets
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Second, there is a considerable difference regarding the
spatial resolution of both imaging methods used. Raman
spectroscopic imaging is performed by stepwise moving the
laser beam over the sample in a raster pattern, while
simultaneously taking a single Raman spectrum at each stop,
creating an array of pixels. Subsequently, band integrations are
Figure 4.  Label-free Raman imaging of primary human islets of Langerhans.  (A) Brightfield microscopy image of a
cryosection of an islet of Langerhans. (B) Fluorescence microscopy image of the islet stained for DNA (blue), insulin (red) and
glucagon (green). (C) Corresponding Raman cluster image and (D) corresponding Raman cluster spectra, acquired by scanning the
confocal laser bundle in a 64x64 raster pattern. Analysis with 3 levels of clustering illustrates the spatial variation of Raman signal
within the islet. Enlargement shows the disulfide band at 520 and the tryptophan band at 1552 cm-1. Spectra are vertically offset for
clear representation. The bottom panel shows hyperspectral Raman images for (E) DNA (783 cm-1, Δ = 26 cm-1), (F) disulfide
bridges between cysteine groups (524 cm-1, Δ = 30 cm-1) and (G) tryptophan (1545 cm-1, Δ = 21 cm-1). Minor artifacts caused by
the image-stitching procedure are visible in the Raman images. Scale bar represents 50 µm.
doi: 10.1371/journal.pone.0078148.g004
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performed on bands of interest and with these data an image is
reconstructed. The spatial resolution of the Raman image is
thus determined by the step size of the laser focal spot. For
detailed Raman imaging on islets, we used a step size of 0.94
µm. In comparison, the resolution of fluorescence microscopy
is limited by the diffraction of light to a few hundred
nanometers. Last, the same islet section was first imaged using
Raman spectroscopy and subsequently immunolabeled for
fluorescence microscopy, for which two separate microscope
systems were used.
Our findings show that high-resolution hyperspectral Raman
imaging with a step size smaller than 1 µm, enables the label-
free distinction of insulin and glucagon within human islets of
Langerhans. However, it does not yet provide information on
the viability of the tissue or determines the islets’ ability to
respond to a glucose stimulus. On the other hand, Notingher
and colleagues have already reported the use of Raman
spectroscopy to distinguish viable from dead cells [44]. Their
findings suggest the possibility of using Raman spectroscopy to
quantify viability of pancreatic islet grafts. Further studies need
to be performed to investigate the feasibility of performing real-
time studies on viability and functioning of islet preparations
using confocal Raman spectroscopy. In such analysis, it will
also be beneficial to correlate the islet parameters to the final
patient outcome after transplantation. This would help selecting
optimal tissue for transplantation [45,46].
Conclusion
We demonstrate, in contrast to conventional histological
methods, that Raman spectroscopy enables the label-free
classification of various cell types in human islets and
pancreatic cell lines. Measurements on purified hormones
revealed Raman markers specific for disulfide bridges between
cysteine groups (520 cm-1) and tryptophan (1552 cm-1) that can
be used to distinguish between insulin and glucagon. High-
resolution Raman imaging, using sub-micrometer steps, for
these specific bands enables local detection of high
concentrations of insulin and glucagon in human pancreatic
islet cells. This method provides information on composition
and structural organization of pancreatic endocrine tissue in a
label-free manner, and may help to accurately monitor islet
quality before transplantation in patients suffering from type 1
diabetes in the future.
Figure 5.  Label-free detection of insulin and glucagon in human islets.  The top panel shows the univariate Raman images of
a cryosection of an islet of Langerhans for (A) DNA (783 cm-1, Δ = 26 cm-1), (B) disulfide bridges between cysteine groups (524
cm-1, Δ = 30 cm-1) and (C) tryptophan (1545 cm-1, Δ = 21 cm-1). The second panel shows the corresponding fluorescence
microscopy images stained for (E) DNA, (F) insulin and (G) glucagon. The bottom panel shows the overlay images of the Raman
image (in purple) and fluorescence image (green) for (I) DNA, (J) insulin and (K) glucagon. (D) Merged Raman spectroscopy image
images of DNA (blue), difsulfide bridged cysteine (red) and tryptophan (green). (H) Merged fluorescence image of DAPI (blue),
insulin (red) and glucagon (green). Scale bar represents 50 µm.
doi: 10.1371/journal.pone.0078148.g005
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